Purdue Pharma wants a lawsuit dismissed that accuses the company of profiting from the opioid crisis by aggressively marketing OxyContin.
This is the second motion to dismiss filed by the company’s legal defense.
The court did not initially rule on the first motion because the Attorney General’s office amended the complaint. The commonwealth released the heavily redacted complaint that accuses the company of contributing to the opioid crisis.
Suffolk County Superior Court Judge Janet Sanders ruled that the unredacted amended suit be released in January. The redactions revealed internal company documents and email correspondence between top executives, some of whom are named as defendants.
Purdue says the prosecution’s narrative is «sensationalist» and «distorted» and that internal documents published in the new complaint were mischaracterized and taken out of context.
